Marinela Capanu

Statistics

Publications

Citations

104

H-Index

Active since

2014

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Molecular Oncology (United States)

Cornell University

Marinela Capanu is an author at Memorial Sloan Kettering Cancer Center specializing in cancer immunotherapy, medicine, and esophageal cancer pharmacotherapy.

Publications per year

2014–2023

Publications

First-line regorafenib with nivolumab and chemotherapy in advanced oesophageal, gastric, or gastro-oesophageal junction cancer in the USA: a single-arm, single-centre, phase 2 trial

Samuel Cytryn, Ryan H. Moy, Darren Cowzer et al. · The Lancet Oncology · 2023 · 45 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

Targeted Molecular Profiling of Circulating Cell-Free DNA in Patients With Advanced Hepatocellular Carcinoma

Darren Cowzer, Jessica White, Joanne F. Chou et al. · JCO Precision Oncology · 2023 · 18 citations · Full text

Medicine, Molecular Medicine, Oncology +17

First-line pembrolizumab (P), trastuzumab (T), capecitabine (C) and oxaliplatin (O) in HER2-positive metastatic esophagogastric adenocarcinoma.

Yelena Y. Janjigian, Steven B. Maron, Joanne F. Chou et al. · Journal of Clinical Oncology · 2019 · 16 citations

Medicine, Immunology, Pharmacology +16

Durvalumab and PET-Directed Chemoradiation in Locally Advanced Esophageal Adenocarcinoma

Darren Cowzer, Abraham J. Wu, Smita Sihag et al. · Annals of Surgery · 2023 · 14 citations · Full text

Medicine, Oncology, Surgery +17

A phase II study of afatinib in patients (pts) with metastatic human epidermal growth factor receptor (HER2)-positive trastuzumab-refractory esophagogastric (EG) cancer.

Yelena Y. Janjigian, Marinela Capanu, Tooba Imtiaz et al. · Journal of Clinical Oncology · 2014 · 11 citations

Medicine, Oncology, Pharmacology +17

1–5 of 5